OOIR: Observatory of International Research

Papers

(The TQCC of International Clinical Psychopharmacology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Netwo	35
Antidepressant psychopharmacology: is inflammation a future target?	24
The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy: an observational study	22
Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials	19
Effects of celecoxib augmentation of antidepressant or anxiolytic treatment on affective symptoms and inflammatory markers in patients with anxiety disorders: exploratory study	14
Clinical specificity profile for novel rapid acting antidepressant drugs	14
Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial	14
Use of subcutaneous ketamine to rapidly improve severe treatment-resistant depression in a patient with Alzheimer’s disease	13
Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts	13
Vortioxetine improves cognition in mild cognitive impairment	12
Tolcapone in obsessive-compulsive disorder: a randomized double-blind placebo-controlled crossover trial	12
Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies	11
Antidepressant efficacy is correlated with plasma levels: mega-analysis and further evidence	11
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	11
Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms	10
Risperidone combination therapy with adalimumab for treatment of chronic schizophrenia: a randomized, double-blind, placebo-controlled clinical trial	10
Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain	10
Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder	10
The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial	10
Atypical antipsychotics in the treatment of psychotic symptoms in Alzheimer’s disease: a systematic review	10
Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report	9
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial	9
Infection is associated with elevated serum concentrations of antipsychotic drugs	9
Persistent suicidal ideation in major depressive disorder patients: still in need of empathic understanding	9
Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: a prospective naturalistic study	9

Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol	9
Adjunctive music improves the tolerability of intravenous ketamine for bipolar depression	8
The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?	8
Predictors of discontinuation and hospitalization during long-acting injectable antipsychotic treatment in patients with schizophrenia spectrum disorder	7
Efficacy and safety of lurasidone in schizophrenia: pooled analysis of European results from double-blind, placebo-controlled 6-week studies	7
Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial	7
Prevalence and predictors of laxatives use in clozapine-related constipation: an observational study	7
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	7
Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study	6
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features	6
Can bupropion treat COVID-19–induced brain fog? A case series	6
Trends of complications in patients with Parkinson’s disease in seven major cities of China from 2016 to 2019	6
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	6
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	6
Levetiracetam adjunct to quetiapine for the acute manic phase of bipolar disorder: a randomized, double-blind and placebo-controlled clinical trial of efficacy, safety and tolerability	5
Ketamine for depression: a potential role in requests for Medical Aid in Dying?	5
Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10	5
Cardiovascular risk factors and metabolic syndrome in patients treated with long-acting injectables antipsychotics: a retrospective study	5
Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations	5
Risk of conversion to bipolar disorder in patients with late-onset major depression	5
Unhealthy lifestyle impacts on biological systems involved in stress response: hypothalamic–pituitary–adrenal axis, inflammation and autonomous nervous system	5
Clinical and demographic factors associated with early relapse in patients with schizophrenia: a naturalistic observation study	5
Psychopharmacology: past, present and future	5
Social withdrawal and neurocognitive correlates in schizophrenia	5
Acceptability of transdermal antipsychotic patches by patients who refuse oral medication and their effectiveness in preventing recurrence of delirium: a retrospective observational study	5
An investigation into the association between suicide mortality rate and lithium levels in potable water: a review study	4
Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders	4
Paradoxical effect of statin medication on depressive disorder in first-ever ischemic stroke patients: possible antidepressant-like effect prestroke and the opposite in continuous medication poststrok	4
The efficacy and safety in attention deficit hyperactivity disorder of second-generation antipsychotics and other medications for hyperactivity in children and adolescents with autism: a meta-analysis	4
Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review	4
Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database	4
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	4
Pharmacologic treatment of depression in Alzheimer’s disease	4
Clinical outcomes after clozapine discontinuation in responders versus nonresponders: a retrospective chart review	4
Lamotrigine-induced mania: warning report for the identification of vulnerable populations and expert clinical recommendations for prescription	4
Efficacy of cariprazine in patients with bipolar depression and higher or lower levels of baseline anxiety: a pooled post hoc analysis	4
Amisulpride steady-state plasma concentration and adverse reactions in patients with schizophrenia: a study based on therapeutic drug monitoring data	4
Advances in the treatment of depression	4
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder	4
Occurrence of involuntary movements after prolonged misuse of zolpidem: a case report	4
The role of personality traits in following quarantine orders during the COVID-19 pandemic	4
Can levetiracetam improve clinical symptoms in schizophrenic patients? A randomized placebo-controlled clinical trial	4
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?	4
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students	4
Phosphodiesterase inhibitor and selective serotonin reuptake inhibitor combination therapy versus monotherapy for the treatment of major depressive disorder: a systematic review and meta-analysis	4
Safety and efficacy of daridorexant in the treatment of insomnia: a systematic review and meta-analysis of randomized controlled trials	4
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	4
Successful treatment of switching from benzodiazepine to orexin receptor antagonists improves cognitive function in psychiatric disorders: four case reports	4